Generation of adaptive HER2-specific immunity in HER2 breast cancer patients by addition of trastuzumab to chemotherapy in the adjuvant setting: NCCTG (Alliance) study N9831
- Citation:
- J Clin Oncol vol 31 (15 suppl) abstr 522
- Meeting Instance:
- ASCO 2013
- Year:
- 2013
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2249
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- K. L. Knutson E. A. Perez K. Ballman C. L. Erskine N. Fox C.-A. Mccarl N. Norton S. V. Sumrall D. Northfelt W. Tan C. Calfa M. Pegram R. Clynes
- Networks:
- Study
- NCCTG-N9831
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: